Subcutaneous injection sites impact brain uptake of blood-brain barrier impermeable paclitaxel

다국어 초록 (Multilingual Abstract)

Purpose Systemic absorption is the process of drug movement from the site of drug administration to systemic circulation for therapeutic efficacy. Systemic absorption and distribution of therapeutics are affected by the route of administration and may further vary with different sites for the same route. Paclitaxel (PTX) remains one of the most powerful chemotherapeutic drugs to treat various tumors. Nevertheless, PTX has not been used to treat brain tumors because of its blood-brain barrier (BBB) impermeability and lack of drug accumulation in the brain. This study aimed to investigate systemic absorption and brain uptake of PTX following subcutaneous (SC) injection at different sites.
Methods A hydroxypropyl methylcellulose (HPMC) polymer was used to prepare the PTX-HPMC hydrogel. The PTXHPMC hydrogel was characterized by sol-gel transition, drug release, and in situ hydrogel formation. Systemic absorption and distribution in the brain were investigated in mice after subcutaneous injection at three different sites (flank, head, and abdomen). The PTX concentrations in the plasma and brain homogenates were quantified using LC-MS/MS using the liquidliquid extraction method.
Results The PTX-HPMC hydrogel showed sol-gel transition at 37 ℃ and bi-phase release with burst and sustained release.
Systemic absorption in the plasma at all SC injection sites showed no significant differences. However, the distribution to the brain after SC injection at the head was 2.5 times higher than at the flank, suggesting an injection site-dependent distribution of PTX.
Conclusion Differences in blood and lymph flow among SC sites are expected to contribute to PTX distribution. SC injection into the head may be a promising route for drug delivery to brain.

참고문헌 (Reference)

1 Gong C, "Thermosensitive polymeric hydrogels as drug delivery systems" 20 : 79-94, 2013

2 Sarkar N, "Thermal gelation properties of methyl and hydroxypropyl methylcellulose" 24 : 1073-1087, 1979

3 Xu Y, "The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells" 7 : 20890-20901, 2016

4 Ellis H, "The surgical anatomy of the scalp" 32 : e1-e5, 2014

5 Pardridge WM, "The blood-brain barrier : bottleneck in brain drug development" 2 : 3-14, 2005

6 Klemp P, "Subcutaneous blood flow in early male pattern baldness" 92 : 725-726, 1989

7 Ardilouze JL, "Subcutaneous adipose tissue blood flow varies between superior and inferior levels of the anterior abdominal wall" 28 : 228-233, 2004

8 Gradel AKJ, "Subcutaneous Administration of insulin is Associated with Regional differences in Injection Depot variability and kinetics in the rat" 128 : 332-338, 2020

9 Shimizu S, "Routes of administration" 1 : 527-547, 2004

10 김유철 ; Kyoung Ah Min ; Dong‑Jin Jang ; Tae Young Ahn ; Jae Hyeok Min ; Byeong Eun Yu ; 조관형, "Practical approaches on the long‑acting injections" 한국약제학회 50 (50): 147-157, 2020

11 Almeida N, "Phase behavior of concentrated hydroxypropyl methylcellulose solution in the presence of mono and divalent salt" 99 : 630-637, 2014

12 Anselmo AC, "Non-invasive delivery strategies for biologics" 18 : 19-40, 2019

13 Hegde Manasa Manjunath ; Prabhu Suma ; Mutalik Srinivas ; Chatterjee Abhishek ; Goda Jayant S. ; Satish Rao B. S., "Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches" 한국약제학회 52 (52): 49-74, 2022

14 Kang JH, "Intraosseous administration into the skull: potential blood–brain barrier bypassing route for brain drug delivery" e10424-, 2022

15 Habimana-Griffin L, "Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents" 25 : 1-13, 2020

16 Zhang K, "Injectable gel self-assembled by paclitaxel itself for in situ inhibition of tumor growth" 315 : 197-205, 2019

17 Sayed Hassan Auda ; Saleh Abd El-Rasoul ; Mahmoud Mohamed Ahmed ; Shaaban Khalaf Osman ; Mahmoud El-Badry, "In-vitro release and in-vivo performance of tolmetin from different topical gel formulations" 한국약제학회 45 (45): 311-317, 2015

18 Zou P, "Impact of injection sites on clinical pharmacokinetics of subcutaneously administered peptides and proteins" 336 : 310-321, 2021

19 Guarve K, "HPMC-A Marvel Polymer for Pharmaceutical Industry-Patent Review" 15 : 46-58, 2021

20 Patel MM, "Getting into the brain" 23 : 35-58, 2009

21 Wang Y, "Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery" 6 : 1497-1507, 2011

22 Konno T, "Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers" 65 : 209-214, 2003

23 Liu S, "Effects of salts in the Hofmeister series and solvent isotopes on the gelation mechanisms for hydroxypropylmethylcellulose hydrogels" 109 : 363-372, 2008

24 Gao P, "Development of a supersaturable SEDDS(S-SEDDS)formulation of paclitaxel with improved oral bioavailability" 92 : 2386-2398, 2003

25 Mathew EN, "Delivering therapeutics to glioblastoma : overcoming biological constraints" 23 : 1711-, 2022

26 Wang Z, "Current development of Glioblastoma Therapeutic Agents" 20 : 1521-1532, 2021

27 Taylor NA, "Considerations for the measurement of core, skin and mean body temperatures" 46 : 72-101, 2014

28 Zhao M, "Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection" 309 : 72-81, 2019

29 Mcfaline-Figueroa JR, "Brain Tumors" 131 : 874-882, 2018

30 Larsen OA, "Blood flow through human adipose tissue determined with radioactive xenon" 66 : 337-345, 1966

31 Bastiancich C, "Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma" 243 : 29-42, 2016

32 Korea Central Cancer Registry NCC, "Annual report of cancer statistics in Korea in 2019" Ministry of Health and Welfare 2021

33 Turner PV, "Administration of substances to laboratory animals : routes of administration and factors to consider" 50 : 600-613, 2011

34 Iwami K, "A novel method of intracranial injection via the postglenoid foramen for brain tumor mouse models" 116 : 630-635, 2012